SOCS1 and graft versus host disease: Parallel in vitro and in vivo analyses demonstrated that SOCS1 inhibited T cell activation and dampened GVHD by inhibiting several inflammatory signaling pathway including JAK2/STAT3 signaling and NLRP3 inflammasome signaling.